CITIUS ONCOLOGY INC (CTOR) Stock Analyst Earnings Estimates
NASDAQ:CTOR - Nasdaq - US17331Y1091 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 42.80% | ||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.857M | -12.121M -149.58% | -20.573M -69.73% | N/A -29.47% | N/A 195.43% | N/A 97.93% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A 110.42% | N/A 960.00% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 | -0.12 | 0.06 168.00% | 0.01 109.27% |
| Revenue Q2Q % growth | 17.098M | 17.842M | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.183M -1,510.22% | -6.308M 68.34% | 5.847M 191.43% | 6.101M 181.66% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.11 | -0.09 | -0.02 | -19.83% |
| Q1 2025 Q2Q % growth | -0.09 | -0.06 | -0.03 | -47.06% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 5.851M | -5.851M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -114.29% | 0% | -100% |
| Revenue | N/A | -100% | N/A | -100% |